A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers
Clinical trial NCT04581772 · COMPLETED
Trial details
- NCT number
- NCT04581772
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2021-06-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.